TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Cyclopharm Limited ( (AU:CYC) ) has issued an update.
Cyclopharm Limited has released its corporate governance statement for the financial year ending December 31, 2024, which is available on their website. The statement outlines the company’s adherence to the ASX Corporate Governance Council’s principles, highlighting their commitment to transparency and accountability in management and oversight. This announcement reinforces Cyclopharm’s dedication to maintaining high governance standards, potentially strengthening its position in the market and assuring stakeholders of its robust governance practices.
More about Cyclopharm Limited
Cyclopharm Limited operates in the healthcare industry, focusing on medical technology and services. The company is known for its innovative products aimed at improving patient outcomes and enhancing diagnostic processes.
YTD Price Performance: -24.05%
Average Trading Volume: 164,691
Technical Sentiment Signal: Buy
Current Market Cap: A$133.4M
Learn more about CYC stock on TipRanks’ Stock Analysis page.